Welcome to the Investors section of the Combat Medical website. Here you will find the latest information relating to our products, which will include product updates, trial updates and news.

Latest News

The Scaleup Programme: supporting 30 companies for rapid growth | EEN

Combat Medical Ltd is proud to have been selected for The Scaleup Programme: supporting 30

More

COMBAT are exhibiting at BAUS 2018- 25th-27th Liverpool at the ACC. Stand 510

COMBAT are exhibiting at BAUS 2018- 25th-27th Liverpool at the ACC. Stand 510 Abstracts being

More

AUA2018 MAY 18-21 San Francisco: Stand 5358

Over 200 HIVEC patients RWD being presented in 2 clinical abstracts at AUA -Retrospective analysis

More

AUA18 – Mon 21st May 2018, 9:30-11:30, MCC West 3005

MP83-09_Chemohyperthermia with Mitomycin C and COMBAT System a new alternative to BCG in high risk

More

AUA18 – Mon 21st May 2018 13:00-15:00, (podium 2:40-2:50) MCC WEST, 3024

PD66-11_Hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer. Joep de Jong*,The Journal of Urology,

More

EAU2018 Copenhagen – Stand A26

Combat will again be exhibiting at this years EAU in Copenhagen. Please come and visit

More

For the latest results for HIVEC and the use of the COMBAT System, attend this session at the 2018 Genitourinary Cancers Symposium!

For the latest results for HIVEC and the use of the COMBAT System, attend this

More

Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center

More

Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.

More

The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy

More